INDEGENE Financial Statement Analysis
|
||
|
The Revenues of INDEGENE have increased by 9.64% YoY .
The Earnings Per Share (EPS) of INDEGENE has decreased by -1.77 % YoY. |
||
INDEGENE Last 5 Annual Financial Results
[BOM: 544172|NSE : INDGN]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Operating Income | ₹2,839 Cr | ₹2,590 Cr | ₹2,306 Cr | ₹1,665 Cr | ₹966 Cr |
| Operating Expenses | ₹172 Cr | ₹168 Cr | ₹201 Cr | ₹214 Cr | ₹119 Cr |
| Expenses | ₹2,305 Cr | ₹2,084 Cr | ₹1,910 Cr | ₹1,378 Cr | ₹736 Cr |
| Operating Profit (Excl OI) | ₹534 Cr | ₹505 Cr | ₹396 Cr | ₹287 Cr | ₹231 Cr |
| Other Income | ₹107 Cr | ₹76 Cr | ₹58 Cr | ₹26 Cr | ₹31 Cr |
| Interest | ₹22 Cr | ₹49 Cr | ₹31 Cr | ₹5.96 Cr | ₹6.96 Cr |
| Depreciation | ₹80 Cr | ₹76 Cr | ₹60 Cr | ₹33 Cr | ₹26 Cr |
| Profit Before Tax | ₹539 Cr | ₹459 Cr | ₹363 Cr | ₹226 Cr | ₹231 Cr |
| Profit After Tax | ₹407 Cr | ₹337 Cr | ₹266 Cr | ₹163 Cr | ₹186 Cr |
| Consolidated Net Profit | ₹407 Cr | ₹337 Cr | ₹266 Cr | ₹165 Cr | ₹149 Cr |
| Earnings Per Share (Rs) | ₹16.68 | ₹16.98 | ₹15.17 | ₹12.01 | ₹938.81 |
| PAT Margin (%) | 11.43 | 14.32 | 13.00 | 11.54 | 9.78 |
| ROE(%) | 14.14 | 20.45 | 27.56 | 29.50 | 30.20 |
| ROCE(%) | 18.92 | 25.24 | 30.88 | 35.20 | 41.09 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.29 | 0.38 | 0.02 |
Key Financials |
||
| Market Cap | : | ₹ 13,613.3 Cr |
| Revenue (TTM) | : | ₹ 3,812.8 Cr |
| Net Profit(TTM) | : | ₹ 400.9 Cr |
| EPS (TTM) | : | ₹ 16.6 |
| P/E (TTM) | : | 34.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDEGENE | 2.4% | 11.4% | -0.2% |
| SAGILITY | -1% | 3.3% | -5.1% |
| SYNGENE INTERNATIONAL | 2.2% | -2.5% | -41.6% |
| PRIME FOCUS | -8.2% | -1.5% | 74.9% |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | -4.6% | NA | -6.3% |
| NESCO | 0.5% | -2.5% | -23% |
| LATENT VIEW ANALYTICS | -2.3% | -3.3% | -27.5% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -6.8% | -18.4% | 40.7% |
| CMS INFO SYSTEMS | -7.7% | -4% | -39.5% |
INDEGENE Revenues
[BOM: 544172|NSE : INDGN]
| Y-o-Y | 9.64 % |
| 5 Yr CAGR | 30.93 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,839 Cr | 9.64 | |
| Mar2025 | ₹2,590 Cr | 12.29 | |
| Mar2024 | ₹2,306 Cr | 38.54 | |
| Mar2023 | ₹1,665 Cr | 72.27 | |
| Mar2022 | ₹966 Cr | - | |
INDEGENE Operating Profit
[BOM: 544172|NSE : INDGN]
| Y-o-Y | 5.72 % |
| 5 Yr CAGR | 23.39 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹534 Cr | 5.72 | |
| Mar2025 | ₹505 Cr | 27.66 | |
| Mar2024 | ₹396 Cr | 37.98 | |
| Mar2023 | ₹287 Cr | 24.46 | |
| Mar2022 | ₹231 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -3.59 % |
| 5 Yr CAGR | -5.76 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 18.82% | -3.59 | |
| Mar2025 | 19.52% | 13.69 | |
| Mar2024 | 17.17% | -0.41 | |
| Mar2023 | 17.24% | -27.75 | |
| Mar2022 | 23.86% | - | |
INDEGENE Profit After Tax
[BOM: 544172|NSE : INDGN]
| Y-o-Y | 20.79 % |
| 5 Yr CAGR | 28.45 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹407 Cr | 20.79 | |
| Mar2025 | ₹337 Cr | 26.53 | |
| Mar2024 | ₹266 Cr | 61.51 | |
| Mar2023 | ₹165 Cr | 10.28 | |
| Mar2022 | ₹149 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -20.18 % |
| 5 Yr CAGR | 3.97 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 11.43 % | -20.18 | |
| Mar2025 | 14.32 % | 10.15 | |
| Mar2024 | 13 % | 12.65 | |
| Mar2023 | 11.54 % | 18.00 | |
| Mar2022 | 9.78 % | - | |
INDEGENE Earnings Per Share (EPS)
[BOM: 544172|NSE : INDGN]
| Y-o-Y | -1.77 % |
| 5 Yr CAGR | -63.49 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹17 | -1.77 | |
| Mar2025 | ₹17 | 11.93 | |
| Mar2024 | ₹15 | 26.31 | |
| Mar2023 | ₹12 | -98.72 | |
| Mar2022 | ₹939 | - | |
INDEGENE Return on Capital Employed (ROCE)
[BOM: 544172|NSE : INDGN]
| Y-o-Y | -25.04 % |
| 5 Yr CAGR | -17.62 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 18.92% | -25.04 | |
| Mar2025 | 25.24% | -18.26 | |
| Mar2024 | 30.88% | -12.27 | |
| Mar2023 | 35.2% | -14.33 | |
| Mar2022 | 41.09% | - | |
INDEGENE Share Price vs Sensex
| Current Share Price | : | ₹565.1 |
| Current MarketCap | : | ₹ 13,613.3 Cr |
| Updated EOD on | : | Aug 12,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 2.4% |
11.4% |
-0.2% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
INDEGENE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 400 MIDSMALLCAP INDEX | 0.3% | 1.3% | 8% |
| BSE 250 SMALLCAP INDEX | 0.3% | 1% | 6.2% |
| BSE HEALTHCARE | NA | 2.1% | 14.8% |
| BSE 1000 | -0.2% | 1.3% | 3.5% |
| BSE 500 | -0.3% | 1.3% | 3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MIDSMALLCAP 400 | 0.4% | 1.3% | 9.3% |
| NIFTY MIDSMALLCAP400 50:50 | 0.3% | 1.2% | NA |
| NIFTY SMALLCAP 500 | 0.2% | 1.3% | NA |
| NIFTY SMALLCAP 250 | 0.1% | 0.9% | 7.7% |
| NIFTY500 HEALTHCARE INDEX | 0% | 2.4% | 14.2% |
You may also like the below Video Courses
FAQ about INDEGENE Financials
How the annual revenues of INDEGENE have changed ?
The Revenues of INDEGENE have increased by 9.64% YoY .
How the Earnings per Share (EPS) of INDEGENE have changed?
The Earnings Per Share (EPS) of INDEGENE has decreased by -1.77 % YoY .
Check out Intrinsic Value of Peers of INDEGENE
Compare Stock Analytics of Peers of INDEGENE
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs
